We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $69.2B Turnover 15.26%
1-Year Est. Return 41.24%
This Fund
S&P 500
This Quarter Est. Return
-0.69%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$67.5B
AUM Growth
+$10.9B
Cap. Flow
+$12.7B
Cap. Flow %
18.75%
Top 10 Hldgs %
49.27%
Holding
2,060
New
26
Increased
289
Reduced
1,527
Closed
195
Avg Time Held
6.5 years
Top 10 Avg Time Held
5.9 years
Top 20 Avg Time Held
5.3 years

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$799M
2
AAPL icon
Apple
AAPL
+$563M
3
MSFT icon
Microsoft
MSFT
+$445M
4
AMZN icon
Amazon
AMZN
+$321M
5
AVGO icon
Broadcom
AVGO
+$274M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.2%
2 Technology 23.92%
3 Consumer Staples 7.59%
4 Consumer Discretionary 6.94%
5 Communication Services 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GO icon
1701
Grocery Outlet
GO
$1.29B
$104K ﹤0.01%
14,783
-3,682
-20% -$32K
2025 Q2
3 quarters
SPRY icon
1702
ARS Pharmaceuticals
SPRY
$405M
$104K ﹤0.01%
12,974
-2,165
-14% -$20.7K
2024 Q3
6 quarters
ACVA icon
1703
ACV Auctions
ACVA
$1.78B
$103K ﹤0.01%
24,350
-6,356
-21% -$41.6K
2022 Q2
15 quarters
DDD icon
1704
3D Systems Corp
DDD
$492M
$102K ﹤0.01%
54,476
-2,199
-4% -$4.88K
2020 Q2
23 quarters
JBI icon
1705
Janus International
JBI
$576M
$101K ﹤0.01%
19,664
-5,129
-21% -$33.2K
2023 Q2
11 quarters
CMPX icon
1706
Compass Therapeutics
CMPX
$161M
$98.9K ﹤0.01%
18,703
-5,269
-22% -$30.4K
2023 Q2
11 quarters
ZVRA icon
1707
Zevra Therapeutics
ZVRA
$610M
$98.7K ﹤0.01%
10,594
-2,075
-16% -$18.7K
2024 Q4
5 quarters
RES icon
1708
RPC Inc
RES
$1.31B
$98.5K ﹤0.01%
13,919
-3,456
-20% -$21.5K
2020 Q4
21 quarters
IART icon
1709
Integra LifeSciences
IART
$1.05B
$98.3K ﹤0.01%
10,435
-2,569
-20% -$28.2K
2024 Q3
6 quarters
PCT icon
1710
PureCycle Technologies
PCT
$641M
$97.7K ﹤0.01%
18,831
-4,907
-21% -$40.9K
2021 Q4
17 quarters
ADAM icon
1711
Adamas Trust
ADAM
$700M
$97.4K ﹤0.01%
13,230
-3,297
-20% -$26.3K
2017 Q4
33 quarters
AMPL icon
1712
Amplitude
AMPL
$1.98B
$97.1K ﹤0.01%
14,241
-2,639
-16% -$21.8K
2024 Q3
6 quarters
CRMD icon
1713
CorMedix
CRMD
$581M
$97K ﹤0.01%
14,288
-2,776
-16% -$20.5K
2024 Q3
6 quarters
EGY icon
1714
Vaalco Energy
EGY
$632M
$95.2K ﹤0.01%
15,013
-3,912
-21% -$19.7K
2022 Q4
13 quarters
INDI icon
1715
indie Semiconductor
INDI
$464M
$93.4K ﹤0.01%
29,000
-6,830
-19% -$24.1K
2022 Q2
15 quarters
GEVO icon
1716
Gevo
GEVO
$289M
$92.6K ﹤0.01%
33,922
-8,370
-20% -$17.3K
2025 Q2
3 quarters
PRCH icon
1717
Porch Group
PRCH
$1.99B
$91.1K ﹤0.01%
12,701
-3,146
-20% -$25.1K
2024 Q3
6 quarters
IVR icon
1718
Invesco Mortgage Capital
IVR
$615M
$90.3K ﹤0.01%
11,177
-1,924
-15% -$16.4K
2024 Q4
5 quarters
STKL
1719
DELISTED
SunOpta
STKL
$90K ﹤0.01%
13,884
-3,618
-21% -$20.5K
2022 Q2
15 quarters
FULC icon
1720
Fulcrum Therapeutics
FULC
$280M
$89.4K ﹤0.01%
11,656
+1,397
+14% +$13K
2025 Q4
1 quarter
MGTX icon
1721
MeiraGTx Holdings
MGTX
$950M
$88K ﹤0.01%
10,156
-1,624
-14% -$12.3K
2025 Q4
1 quarter
SLDB icon
1722
Solid Biosciences
SLDB
$615M
$86.6K ﹤0.01%
12,033
-2,185
-15% -$14K
2025 Q2
3 quarters
NAVI icon
1723
Navient
NAVI
$897M
$86.4K ﹤0.01%
10,568
-2,660
-20% -$26.3K
2014 Q2
47 quarters
HTZ icon
1724
Hertz
HTZ
$652M
$86K ﹤0.01%
18,657
-4,383
-19% -$21.2K
2024 Q3
6 quarters
ASAN icon
1725
Asana
ASAN
$2.39B
$85.9K ﹤0.01%
13,427
-2,985
-18% -$26.3K
2023 Q2
11 quarters

Similar funds

ProShare Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, ProShare Advisors held 2,060 positions worth $67.5B, up 19% from $56.7B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

ProShare Advisors deployed $12.7B of net new capital in Q1 2026, opening 26 new positions and adding to 289 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.

By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 0.01% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was NVIDIA, an estimated $799M trimmed.

  • ProShare Advisors's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
  • ProShare Advisors added most to Walmart Inc in Q1 2026, an estimated $729M increase.
  • ProShare Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $799M.
  • ProShare Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $85.7M.
  • ProShare Advisors's ten largest holdings make up 49% of its $67.5B portfolio in Q1 2026.
  • ProShare Advisors opened 26 new positions and closed 195 in Q1 2026.
  • ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $67.5B.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.